Skip to main content
SpringerLink
Log in

Role of Ethnic Differences in Mediators of Energy Balance

  • Chapter
  • First Online:
Impact of Energy Balance on Cancer Disparities

Part of the book series: Energy Balance and Cancer ((EBAC,volume 9))

  • 383 Accesses

Abstract

The rapid increase in the prevalence of obesity in the USA in the past 30 years has many health implications. Obesity is strongly associated with incidence and mortality of several common cancers including post-menopausal breast cancer, renal cell cancer, colorectal cancer, prostate cancer, and endometrial cancer. Obesity patterns in the USA vary substantially by race, particularly for women, with black women having a higher prevalence of obesity than white women. Moreover, black men and women experience higher incidence and mortality for many common cancers and cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pi-Sunyer FX (2000) Obesity: criteria and classification. Proc Nutr Soc 59(4):505–509

    CAS  PubMed  Google Scholar 

  2. Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89(6):2583–2589

    CAS  PubMed  Google Scholar 

  3. Snijder MB, van Dam RM, Visser M, Seidell JC (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35(1):83–92

    CAS  PubMed  Google Scholar 

  4. Willett WC (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, NY

    Google Scholar 

  5. World Health Organization (1997) Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO, Geneva

    Google Scholar 

  6. (1998) Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158(17):1855–1867

    Google Scholar 

  7. Hu FB (2008) Obesity epidemiology, 1st edn. Oxford University Press, New York, NY

    Google Scholar 

  8. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R (1996) Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45(9):1119–1124

    CAS  PubMed  Google Scholar 

  9. Evans EM, Rowe DA, Racette SB, Ross KM, McAuley E (2006) Is the current BMI obesity classification appropriate for black and white postmenopausal women? Int J Obes (Lond) 30(5):837–843

    CAS  Google Scholar 

  10. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB (1996) How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 143(3):228–239

    CAS  PubMed  Google Scholar 

  11. Wagner DR, Heyward VH (2000) Measures of body composition in blacks and whites: a comparative review. Am J Clin Nutr 71(6):1392–1402

    CAS  PubMed  Google Scholar 

  12. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241

    CAS  PubMed  Google Scholar 

  13. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288(14):1723–1727

    PubMed  Google Scholar 

  14. Ogden CL, Carroll MD, Kit BK, Flegal KM (2013) Prevalence of obesity among adults: United States, 2011–2012. NCHS Data Brief No. 131. Hyattsville, MD

    Google Scholar 

  15. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132(6):2087–2102

    PubMed  Google Scholar 

  16. Hill JO, Melanson EL (1999) Overview of the determinants of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 31(11 Suppl):S515–S521

    CAS  PubMed  Google Scholar 

  17. Kumanyika S (1987) Obesity in black women. Epidemiol Rev 9:31–50

    CAS  PubMed  Google Scholar 

  18. Parker JD, Abrams B (1993) Differences in postpartum weight retention between black and white mothers. Obstet Gynecol 81(5 Pt 1):768–774

    CAS  PubMed  Google Scholar 

  19. Patel KA, Schlundt DG (2001) Impact of moods and social context on eating behavior. Appetite 36(2):111–118

    CAS  PubMed  Google Scholar 

  20. Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853–855

    CAS  PubMed  Google Scholar 

  21. Department of Health and Human Services (2008) Physical activity guidelines advisory committee physical activity guidelines advisory committee report, Department of Health and Human Services, Washington, DC

    Google Scholar 

  22. Centers for Disease Control and Prevention (2005) Adult participation in recommended levels of physical activity-United States, 2001 and 2003. Morb Mortal Wkly Rep 54:1208–1212

    Google Scholar 

  23. Ahmed NU, Smith GL, Flores AM, Pamies RJ, Mason HR, Woods KF, Stain SC (2005) Racial/ethnic disparity and predictors of leisure-time physical activity among U.S. men. Ethn Dis 15(1):40–52

    PubMed  Google Scholar 

  24. Crespo CJ, Smit E, Andersen RE, Carter-Pokras O, Ainsworth BE (2000) Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Prev Med 18(1):46–53

    CAS  PubMed  Google Scholar 

  25. Macera CA, Ham SA, Yore MM, Jones DA, Ainsworth BE, Kimsey CD, Kohl HW 3rd (2005) Prevalence of physical activity in the United States: behavioral risk factor surveillance system, 2001. Prev Chronic Dis 2(2):A17

    PubMed  PubMed Central  Google Scholar 

  26. Kimm SY, Glynn NW, Kriska AM, Barton BA, Kronsberg SS, Daniels SR, Crawford PB, Sabry ZI, Liu K (2002) Decline in physical activity in black girls and white girls during adolescence. N Engl J Med 347(10):709–715

    PubMed  Google Scholar 

  27. He XZ, Baker DW (2005) Differences in leisure-time, household, and work-related physical activity by race, ethnicity, and education. J Gen Intern Med 20(3):259–266

    PubMed  PubMed Central  Google Scholar 

  28. Marshall SJ, Jones DA, Ainsworth BE, Reis JP, Levy SS, Macera CA (2007) Race/ethnicity, social class, and leisure-time physical inactivity. Med Sci Sports Exerc 39(1):44–51

    PubMed  Google Scholar 

  29. Jebb SA (2007) Dietary determinants of obesity. Obes Rev 8(Suppl 1):93–97

    PubMed  Google Scholar 

  30. Bowman SA, Vinyard BT (2004) Fast food consumption of U.S. adults: impact on energy and nutrient intakes and overweight status. J Am Coll Nutr 23(2):163–168

    PubMed  Google Scholar 

  31. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79(4):537–543

    CAS  PubMed  Google Scholar 

  32. Bray GA, Paeratakul S, Popkin BM (2004) Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 83(4):549–555

    CAS  PubMed  Google Scholar 

  33. Isganaitis E, Lustig RH (2005) Fast food, central nervous system insulin resistance, and obesity. Arterioscler Thromb Vasc Biol 25(12):2451–2462

    CAS  PubMed  Google Scholar 

  34. Drewnowski A (2007) The real contribution of added sugars and fats to obesity. Epidemiol Rev 29:160–171

    PubMed  Google Scholar 

  35. Lewis CE, Smith DE, Wallace DD, Williams OD, Bild DE, Jacobs DR Jr (1997) Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study. Am J Public Health 87(4):635–642

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Linne Y, Dye L, Barkeling B, Rossner S (2003) Weight development over time in parous women—the SPAWN study—15 years follow-up. Int J Obes Relat Metab Disord 27(12):1516–1522

    CAS  PubMed  Google Scholar 

  37. Brown JE, Kaye SA, Folsom AR (1992) Parity-related weight change in women. Int J Obes Relat Metab Disord 16(9):627–631

    CAS  PubMed  Google Scholar 

  38. Williamson DF, Madans J, Pamuk E, Flegal KM, Kendrick JS, Serdula MK (1994) A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age. Int J Obes Relat Metab Disord 18(8):561–569

    CAS  PubMed  Google Scholar 

  39. Harris HE, Ellison GT, Holliday M (1997) Is there an independent association between parity and maternal weight gain? Ann Hum Biol 24(6):507–519

    CAS  PubMed  Google Scholar 

  40. Lahmann PH, Lissner L, Gullberg B, Berglund G (2000) Sociodemographic factors associated with long-term weight gain, current body fatness and central adiposity in Swedish women. Int J Obes Relat Metab Disord 24(6):685–694

    CAS  PubMed  Google Scholar 

  41. Bastian LA, West NA, Corcoran C, Munger RG (2005) Number of children and the risk of obesity in older women. Prev Med 40(1):99–104

    PubMed  Google Scholar 

  42. Keppel KG, Taffel SM (1993) Pregnancy-related weight gain and retention: implications of the 1990 Institute of Medicine guidelines. Am J Public Health 83(8):1100–1103

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Smith DE, Lewis CE, Caveny JL, Perkins LL, Burke GL, Bild DE (1994) Longitudinal changes in adiposity associated with pregnancy. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. JAMA 271(22):1747–1751

    CAS  PubMed  Google Scholar 

  44. Lee SK, Sobal J, Frongillo EA, Olson CM, Wolfe WS (2005) Parity and body weight in the United States: differences by race and size of place of residence. Obes Res 13(7):1263–1269

    PubMed  Google Scholar 

  45. Cohen SS, Larson CO, Matthews CE, Buchowski MS, Signorello LB, Hargreaves MK, Blot WJ (2009) Parity and breastfeeding in relation to obesity among black and white women in the southern community cohort study. J Womens Health (Larchmt) 18(9):1323–1332

    Google Scholar 

  46. National Center for Health Statistics (2006) Health, United States 2006, with Chartbook on Trends in the Health of Americans. Hyattsville, MD

    Google Scholar 

  47. Szklarska A, Jankowska EA (2003) Independent effects of social position and parity on body mass index among Polish adult women. J Biosoc Sci 35(4):575–583

    PubMed  Google Scholar 

  48. Bernstein L, Teal CR, Joslyn S, Wilson J (2003) Ethnicity-related variation in breast cancer risk factors. Cancer 97(1 Suppl):222–229

    PubMed  Google Scholar 

  49. Ludington-Hoe SM, McDonald PE, Satyshur R (2002) Breastfeeding in African-American women. J Natl Black Nurses Assoc 13(1):56–64

    PubMed  Google Scholar 

  50. Ohlin A, Rossner S (1996) Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res 4(3):271–276

    CAS  PubMed  Google Scholar 

  51. Rooney BL, Schauberger CW (2002) Excess pregnancy weight gain and long-term obesity: one decade later. Obstet Gynecol 100(2):245–252

    PubMed  Google Scholar 

  52. McLaren L (2007) Socioeconomic status and obesity. Epidemiol Rev 29:29–48

    PubMed  Google Scholar 

  53. Robert SA, Reither EN (2004) A multilevel analysis of race, community disadvantage, and body mass index among adults in the US. Soc Sci Med 59(12):2421–2434

    PubMed  Google Scholar 

  54. Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28

    CAS  PubMed  Google Scholar 

  55. Zhang Q, Wang Y (2004) Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000. Obes Res 12(10):1622–1632

    PubMed  Google Scholar 

  56. Zhang Q, Wang Y (2004) Socioeconomic inequality of obesity in the United States: do gender, age, and ethnicity matter? Soc Sci Med 58(6):1171–1180

    PubMed  Google Scholar 

  57. U.S. Cancer Statistics Working Group (2009) United States cancer statistics: 1999–2005 incidence and mortality web-based report, US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA

    Google Scholar 

  58. U.S. Cancer Statistics Working Group (2013) United States cancer statistics: 1999–2010 incidence and mortality web-based report, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA

    Google Scholar 

  59. Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23(38):6365–6378

    CAS  PubMed  Google Scholar 

  60. Abu-Abid S, Szold A, Klausner J (2002) Obesity and cancer. J Med 33(1–4):73–86

    PubMed  Google Scholar 

  61. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574

    PubMed  Google Scholar 

  62. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638

    PubMed  Google Scholar 

  63. IARC (2002) IARC handbooks of cancer prevention. Weight control and physical activity. International Agency for Research on Cancer, Lyon

    Google Scholar 

  64. Anderson GL, Neuhouser ML (2012) Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) 5(4):515–521

    Google Scholar 

  65. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer 124(3):698–712

    CAS  PubMed  Google Scholar 

  66. Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6(2):137–141

    CAS  PubMed  Google Scholar 

  67. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152(6):514–527

    PubMed  Google Scholar 

  68. Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N (2012) Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) 5(4):583–592

    CAS  Google Scholar 

  69. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139

    PubMed  PubMed Central  Google Scholar 

  70. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Veer LJ V 't, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Mulligan AM, O’Malley FP, Weerasooriya N, John EM, Beckmann MW, Hartmann A, Weihbrecht SB, Wachter DL, Jud SM, Loehberg CR, Baglietto L, English DR, Giles GG, McLean CA, Severi G, Lambrechts D, Vandorpe T, Weltens C, Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, Dork T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Perez JI, Menendez Rodriguez P, Zamora P, Benitez J, Ko YD, Fischer HP, Hamann U, Pesch B, Bruning T, Justenhoven C, Brauch H, Eccles DM, Tapper WJ, Gerty SM, Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Lindblom A, Margolin S, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gorski B, Gronwald J, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Kriege M, Tilanus-Linthorst MM, Collee M, Wang-Gohrke S, Pylkas K, Jukkola-Vuorinen A, Mononen K, Grip M, Hirvikoski P, Winqvist R, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Auvinen P, Soini Y, Sironen R, Bojesen SE, Orsted DD, Kaur-Knudsen D, Flyger H, Nordestgaard BG, Holland H, Chenevix-Trench G, Manoukian S, Barile M, Radice P, Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gaborieau V, Devilee P, Huijts PE, Tollenaar RA, Seynaeve C, Dite GS, Apicella C, Hopper JL, Hammet F, Tsimiklis H, Smith LD, Southey MC, Humphreys MK, Easton D, Pharoah P, Sherman ME, Garcia-Closas M (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103(3):250–263

    PubMed  PubMed Central  Google Scholar 

  71. Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350

    PubMed  Google Scholar 

  72. Petekkaya I, Sahin U, Gezgen G, Solak M, Yuce D, Dizdar O, Arslan C, Ayyildiz V, Altundag K (2013) Association of breast cancer subtypes and body mass index. Tumori 99(2):129–133

    PubMed  Google Scholar 

  73. Desantis C, Ma J, Bryan L, Jemal A (2013) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62

    PubMed  Google Scholar 

  74. Bandera EV, Chandran U, Zirpoli G, Gong Z, McCann SE, Hong CC, Ciupak G, Pawlish K, Ambrosone CB (2013) Body fatness and breast cancer risk in women of African ancestry. BMC Cancer 13:475

    PubMed  PubMed Central  Google Scholar 

  75. Hall IJ, Newman B, Millikan RC, Moorman PG (2000) Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151(8):754–764

    CAS  PubMed  Google Scholar 

  76. Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4(3):157–173

    CAS  PubMed  Google Scholar 

  77. Mayberry RM (1994) Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol 4(3):205–213

    CAS  PubMed  Google Scholar 

  78. Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, Lesko SM, Shapiro S (1987) Risk factors for breast cancer in black women. J Natl Cancer Inst 78(2):213–217

    CAS  PubMed  Google Scholar 

  79. Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L (2005) Body mass index and breast cancer risk in African American women. Ann Epidemiol 15(2):123–128

    PubMed  Google Scholar 

  80. Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L (2007) A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16(9):1795–1802

    PubMed  Google Scholar 

  81. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL (2011) Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol 173(2):201–216

    PubMed  PubMed Central  Google Scholar 

  82. Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45(1):1–16

    CAS  PubMed  Google Scholar 

  83. Carmichael AR, Bates T (2004) Obesity and breast cancer: a review of the literature. Breast 13(2):85–92

    CAS  PubMed  Google Scholar 

  84. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control 13(8):741–751

    PubMed  Google Scholar 

  85. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223):543–546

    CAS  PubMed  Google Scholar 

  86. White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR (2012) Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer 131(5):E705–E716

    CAS  PubMed  Google Scholar 

  87. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

    Google Scholar 

  88. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK (2008) Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100(23):1672–1694

    PubMed  PubMed Central  Google Scholar 

  89. Lipworth L, McLaughlin JK, Tarone RE, Blot WJ (2011) Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev 20(4):331–333

    PubMed  PubMed Central  Google Scholar 

  90. Lipworth L, Tarone RE, McLaughlin JK (2011) Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer 11:133

    PubMed  PubMed Central  Google Scholar 

  91. Desantis C, Naishadham D, Jemal A (2013) Cancer statistics for African Americans, 2013. CA Cancer J Clin 63:151–166

    PubMed  Google Scholar 

  92. Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N (2011) Rate of renal cell carcinoma subtypes in different races. Int Braz J Urol 37(1):29–32, discussion 33–24

    PubMed  Google Scholar 

  93. Ildaphonse G, George PS, Mathew A (2009) Obesity and kidney cancer risk in men: a meta-analysis (1992–2008). Asian Pac J Cancer Prev 10(2):279–286

    PubMed  Google Scholar 

  94. Mathew A, George PS, Ildaphonse G (2009) Obesity and kidney cancer risk in women: a meta-analysis (1992–2008). Asian Pac J Cancer Prev 10(3):471–478

    PubMed  Google Scholar 

  95. Klinghoffer Z, Yang B, Kapoor A, Pinthus JH (2009) Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Rev Anticancer Ther 9(7):975–987

    PubMed  Google Scholar 

  96. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578

    PubMed  Google Scholar 

  97. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15(1):35–43

    PubMed  Google Scholar 

  98. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2012) An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer 132:2640–2647

    Google Scholar 

  99. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A (2012) Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res 2012:789174

    PubMed  PubMed Central  Google Scholar 

  100. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, Du B, Brogi E, Crawford CB, Kopelovich L, Subbaramaiah K, Dannenberg AJ (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila) 4(7):1021–1029

    CAS  Google Scholar 

  101. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA (2012) Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (Phila) 5(11):1260–1272

    CAS  Google Scholar 

  102. Renehan AG, Roberts DL, Dive C (2008) Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114(1):71–83

    CAS  PubMed  Google Scholar 

  103. Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915–928

    CAS  PubMed  Google Scholar 

  104. Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ (2010) Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19(9):2298–2306

    CAS  PubMed  PubMed Central  Google Scholar 

  105. Braun S, Bitton-Worms K, LeRoith D (2011) The link between the metabolic syndrome and cancer. Int J Biol Sci 7(7):1003–1015

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Wysocki PJ, Wierusz-Wysocka B (2010) Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Rev Mol Diagn 10(4):509–519

    CAS  PubMed  Google Scholar 

  107. Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ (2010) Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocr Relat Cancer 17(1):51–60

    CAS  PubMed  PubMed Central  Google Scholar 

  108. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48–60

    CAS  PubMed  PubMed Central  Google Scholar 

  109. Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, Soderberg S, Lenner P, Janzon L, Riboli E, Berglund G, Hallmans G (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13(4):307–316

    PubMed  Google Scholar 

  110. Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, Rinaldi S, Riboli E, Seidell JC, Grobbee DE, Peeters PH (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106(1):90–95

    CAS  PubMed  Google Scholar 

  111. Renehan AG, Egger M, Minder C, O'Dwyer ST, Shalet SM, Zwahlen M (2005) IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115(6):1006–1007, author reply 1008

    CAS  PubMed  Google Scholar 

  112. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363(9418):1346–1353

    CAS  PubMed  Google Scholar 

  113. Shi R, Yu H, McLarty J, Glass J (2004) IGF-I and breast cancer: a meta-analysis. Int J Cancer 111(3):418–423

    CAS  PubMed  Google Scholar 

  114. Sugumar A, Liu YC, Xia Q, Koh YS, Matsuo K (2004) Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111(2):293–297

    CAS  PubMed  Google Scholar 

  115. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Bueno-de-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E, Kaaks R (2006) Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119(3):659–667

    CAS  PubMed  Google Scholar 

  116. Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11(6):530–542

    PubMed  Google Scholar 

  117. Schernhammer ES, Holly JM, Pollak MN, Hankinson SE (2005) Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14(3):699–704

    CAS  PubMed  Google Scholar 

  118. Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121(2):479–483

    CAS  PubMed  Google Scholar 

  119. Pichard C, Plu-Bureau G, Neves ECM, Gompel A (2008) Insulin resistance, obesity and breast cancer risk. Maturitas 60(1):19–30

    CAS  PubMed  Google Scholar 

  120. Kellerer M, von Eye CH, Muhlhofer A, Capp E, Mosthaf L, Bock S, Petrides PE, Haring HU (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer 62(5):501–507

    CAS  PubMed  Google Scholar 

  121. Rosendahl A, Forsberg G (2004) Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines. Int J Oncol 25(5):1327–1336

    CAS  PubMed  Google Scholar 

  122. Rosendahl AH, Forsberg G (2006) IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Kidney Int 70(9):1584–1590

    CAS  PubMed  Google Scholar 

  123. Cheung CW, Vesey DA, Nicol DL, Johnson DW (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65(4):1272–1279

    CAS  PubMed  Google Scholar 

  124. Ramp U, Jaquet K, Reinecke P, Schardt C, Friebe U, Nitsch T, Marx N, Gabbert HE, Gerharz CD (1997) Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. J Urol 157(6):2345–2350

    CAS  PubMed  Google Scholar 

  125. Schips L, Zigeuner R, Ratschek M, Rehak P, Ruschoff J, Langner C (2004) Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. Am J Clin Pathol 122(6):931–937

    CAS  PubMed  Google Scholar 

  126. Liao LM, Weinstein SJ, Pollak M, Li Z, Virtamo J, Albanes D, Chow WH, Purdue MP (2013) Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 34(1):109–112

    PubMed  PubMed Central  Google Scholar 

  127. Major JM, Pollak MN, Snyder K, Virtamo J, Albanes D (2010) Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer 103(1):132–135

    CAS  PubMed  PubMed Central  Google Scholar 

  128. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiebaut A, Gonzalez CA, Quiros JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12(4):1071–1082

    CAS  PubMed  Google Scholar 

  129. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616

    CAS  PubMed  Google Scholar 

  130. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24):1856–1865

    CAS  PubMed  Google Scholar 

  131. Catalano MG, Frairia R, Boccuzzi G, Fortunati N (2005) Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells. Mol Cell Endocrinol 230(1–2):31–37

    CAS  PubMed  Google Scholar 

  132. Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjonneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Tehard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martinez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hemon B, Norat T, Riboli E, Kaaks R (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16(5):561–572

    PubMed  Google Scholar 

  133. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Hankinson SE (2005) Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 14(9):2147–2153

    CAS  PubMed  Google Scholar 

  134. Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE (2000) Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer 82(11):1867–1870

    CAS  PubMed  PubMed Central  Google Scholar 

  135. Setiawan VW, Haiman CA, Stanczyk FZ, Le Marchand L, Henderson BE (2006) Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 15(10):1849–1855

    CAS  PubMed  Google Scholar 

  136. Woolcott CG, Shvetsov YB, Stanczyk FZ, Wilkens LR, White KK, Caberto C, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT (2010) Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer 17(1):125–134

    CAS  PubMed  PubMed Central  Google Scholar 

  137. Key TJ (2011) Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women. Steroids 76(8):812–815

    CAS  PubMed  Google Scholar 

  138. Endogenous Hormones and Breast Cancer Collaborative Group (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 14(10):1009–1019

    Google Scholar 

  139. Lamon-Fava S, Barnett JB, Woods MN, McCormack C, McNamara JR, Schaefer EJ, Longcope C, Rosner B, Gorbach SL (2005) Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women. J Clin Endocrinol Metab 90(8):4516–4520

    CAS  PubMed  Google Scholar 

  140. Randolph JF Jr, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL (2003) Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 88(4):1516–1522

    CAS  PubMed  Google Scholar 

  141. Marsh EE, Shaw ND, Klingman KM, Tiamfook-Morgan TO, Yialamas MA, Sluss PM, Hall JE (2011) Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab 96(10):3199–3206

    CAS  PubMed  PubMed Central  Google Scholar 

  142. Barnett JB, Woods MN, Rosner B, McCormack C, Longcope C, Houser RF Jr, Gorbach SL (2001) Sex hormone levels in premenopausal African-American women with upper and lower body fat phenotypes. Nutr Cancer 41(1–2):47–56

    CAS  PubMed  Google Scholar 

  143. Key TJ (1999) Serum oestradiol and breast cancer risk. Endocr Relat Cancer 6(2):175–180

    CAS  PubMed  Google Scholar 

  144. Paxton RJ, King DW, Garcia-Prieto C, Connors SK, Hernandez M, Gor BJ, Jones LA (2013) Associations between body size and serum estradiol and sex hormone-binding globulin levels in premenopausal African American women. J Clin Endocrinol Metab 98(3):E485–E490

    CAS  PubMed  PubMed Central  Google Scholar 

  145. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735–6741

    CAS  PubMed  Google Scholar 

  146. Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, Troester MA (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 131(3):1003–1012

    CAS  PubMed  PubMed Central  Google Scholar 

  147. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S (2004) C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24(8):1509–1515

    CAS  PubMed  Google Scholar 

  148. Festa A, D’Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25(10):1407–1415

    CAS  PubMed  Google Scholar 

  149. Ford ES (1999) Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22(12):1971–1977

    CAS  PubMed  Google Scholar 

  150. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289(14):1799–1804

    CAS  PubMed  Google Scholar 

  151. Puglisi MJ, Fernandez ML (2008) Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 138(12):2293–2296

    CAS  PubMed  Google Scholar 

  152. Zhang X, Shu XO, Signorello LB, Hargreaves MK, Cai Q, Linton MF, Fazio S, Zheng W, Blot WJ (2008) Correlates of high serum C-reactive protein levels in a socioeconomically disadvantaged population. Dis Markers 24(6):351–359

    PubMed  PubMed Central  Google Scholar 

  153. Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14(2):189–206

    CAS  PubMed  Google Scholar 

  154. Fernandez-Riejos P, Najib S, Santos-Alvarez J, Martin-Romero C, Perez-Perez A, Gonzalez-Yanes C, Sanchez-Margalet V (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010:568343

    PubMed  PubMed Central  Google Scholar 

  155. Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47(1):33–43

    CAS  PubMed  Google Scholar 

  156. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I (2008) Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 28(7):1368–1374

    CAS  PubMed  PubMed Central  Google Scholar 

  157. Crimmins NA, Martin LJ (2007) Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes Rev 8(5):419–423

    CAS  PubMed  Google Scholar 

  158. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H, Kihara S, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 24(7):861–868

    CAS  PubMed  Google Scholar 

  159. Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK (2011) Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 14(2):96–103

    PubMed  PubMed Central  Google Scholar 

  160. Grossmann ME, Cleary MP (2012) The balance between leptin and adiponectin in the control of carcinogenesis—focus on mammary tumorigenesis. Biochimie 94:2164–2171

    CAS  PubMed  Google Scholar 

  161. Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19(4):525–546

    CAS  PubMed  Google Scholar 

  162. Ronti T, Lupattelli G, Mannarino E (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64(4):355–365

    CAS  Google Scholar 

  163. Swarbrick MM, Havel PJ (2008) Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6(2):87–102

    CAS  PubMed  PubMed Central  Google Scholar 

  164. Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M (2007) Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol 40(3):115–120

    CAS  PubMed  Google Scholar 

  165. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26(3):439–451

    CAS  PubMed  Google Scholar 

  166. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA (2005) Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 54(9):2772–2778

    CAS  PubMed  Google Scholar 

  167. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV (2003) Lower serum adiponectin levels in African-American boys. Obes Res 11(11):1384–1390

    CAS  PubMed  Google Scholar 

  168. Araneta MR, Barrett-Connor E (2007) Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring) 15(10):2454–2462

    CAS  Google Scholar 

  169. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N (2005) The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 37(11):695–701

    CAS  PubMed  Google Scholar 

  170. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr (2004) Serum adiponectin in young adults—interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 14(7):492–498

    PubMed  Google Scholar 

  171. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G (2004) Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53(9):2473–2478

    CAS  PubMed  Google Scholar 

  172. Kanaya AM, Wassel Fyr C, Vittinghoff E, Havel PJ, Cesari M, Nicklas B, Harris T, Newman AB, Satterfield S, Cummings SR (2006) Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 91(12):5044–5050

    CAS  PubMed  Google Scholar 

  173. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA (2004) Ethnic differences in adiponectin levels. Metabolism 53(1):1–3

    CAS  PubMed  Google Scholar 

  174. Schutte AE, Huisman HW, Schutte R, Malan L, van Rooyen JM, Malan NT, Schwarz PE (2007) Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol 157(2):181–188

    CAS  PubMed  Google Scholar 

  175. Wassel Fyr CL, Kanaya AM, Cummings SR, Reich D, Hsueh WC, Reiner AP, Harris TB, Moffett S, Li R, Ding J, Miljkovic-Gacic I, Ziv E (2007) Genetic admixture, adipocytokines, and adiposity in Black Americans: the health, aging, and body composition study. Hum Genet 121(5):615–624

    CAS  PubMed  Google Scholar 

  176. Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26(8):2442–2450

    CAS  PubMed  Google Scholar 

  177. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6):1595–1599

    CAS  PubMed  Google Scholar 

  178. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83

    CAS  PubMed  Google Scholar 

  179. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46(4):459–469

    CAS  PubMed  Google Scholar 

  180. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Haring HU, Stumvoll M (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 11(3):368–372

    CAS  PubMed  Google Scholar 

  181. Miljkovic-Gacic I, Wang X, Kammerer CM, Bunker CH, Wheeler VW, Patrick AL, Kuller LH, Evans RW, Zmuda JM (2007) Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage. Metabolism 56(2):234–238

    CAS  PubMed  PubMed Central  Google Scholar 

  182. Hanley AJ, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen YD, Bryer-Ash M, Norris JM, Haffner SM (2007) Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and African-Americans. J Clin Endocrinol Metab 92(7):2665–2671

    CAS  PubMed  Google Scholar 

  183. Anubhuti AS (2008) Leptin and its metabolic interactions: an update. Diabetes Obes Metab 10(11):973–993

    CAS  PubMed  Google Scholar 

  184. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432

    CAS  PubMed  Google Scholar 

  185. Auwerx J, Staels B (1998) Leptin. Lancet 351(9104):737–742

    CAS  PubMed  Google Scholar 

  186. Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS, Caro JF (1996) Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 228(3):733–738

    CAS  PubMed  Google Scholar 

  187. Gautron L, Elmquist JK (2011) Sixteen years and counting: an update on leptin in energy balance. J Clin Invest 121(6):2087–2093

    CAS  PubMed  PubMed Central  Google Scholar 

  188. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, Teo K, Gerstein H, Sharma AM, Yusuf S, Anand SS (2010) Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33(7):1629–1634

    CAS  PubMed  PubMed Central  Google Scholar 

  189. Cohen SS, Fowke JH, Cai Q, Buchowski MS, Signorello LB, Hargreaves MK, Zheng W, Blot WJ, Matthews CE (2012) Differences in the association between serum leptin levels and body mass index in black and white women: a report from the Southern Community Cohort Study. Ann Nutr Metab 60(2):90–97

    CAS  PubMed  PubMed Central  Google Scholar 

  190. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (2006) SEER cancer statistics review, 1975–2003. National Cancer Institute Bethesda, MD. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006

    Google Scholar 

  191. Gibbons GH (2004) Physiology, genetics, and cardiovascular disease: focus on African Americans. J Clin Hypertens (Greenwich) 6(4 Suppl 1):11–18

    Google Scholar 

  192. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345(1):271–279

    CAS  PubMed  Google Scholar 

  193. Treeck O, Lattrich C, Juhasz-Boess I, Buchholz S, Pfeiler G, Ortmann O (2008) Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer 99(8):1246–1250

    CAS  PubMed  PubMed Central  Google Scholar 

  194. Arditi JD, Venihaki M, Karalis KP, Chrousos GP (2007) Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 39(1):9–13

    CAS  PubMed  Google Scholar 

  195. Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, Vasson MP (2009) Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer 16(4):1197–1210

    CAS  PubMed  Google Scholar 

  196. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK (2005) Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 28(11):1263–1269

    CAS  PubMed  Google Scholar 

  197. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86(3):s858–s866

    PubMed  Google Scholar 

  198. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, Fu OY, Chen HY, Hou MF, Yuan SS (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237(1):109–114

    CAS  PubMed  Google Scholar 

  199. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS (2006) Total and high molecular weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92:1041–1048

    PubMed  Google Scholar 

  200. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89(3):1102–1107

    CAS  PubMed  Google Scholar 

  201. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9(15):5699–5704

    CAS  PubMed  Google Scholar 

  202. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA (2007) Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 14(3):669–677

    CAS  PubMed  Google Scholar 

  203. Kang JH, Yu BY, Youn DS (2007) Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 22(1):117–121

    CAS  PubMed  PubMed Central  Google Scholar 

  204. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros C, Hankinson SE (2007) Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92:1510–1516

    CAS  PubMed  Google Scholar 

  205. Liu LY, Wang M, Ma ZB, Yu LX, Zhang Q, Gao DZ, Wang F, Yu ZG (2013) The role of adiponectin in breast cancer: a meta-analysis. PLoS One 8(8):e73183

    CAS  PubMed  PubMed Central  Google Scholar 

  206. Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8(5):395–408

    CAS  PubMed  Google Scholar 

  207. Maccio A, Madeddu C (2011) Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal 11:2020–2036

    PubMed  PubMed Central  Google Scholar 

  208. Spyridopoulos TN, Dessypris N, Antoniadis AG, Gialamas S, Antonopoulos CN, Katsifoti K, Adami HO, Chrousos GP, Petridou ET (2012) Insulin resistance and risk of renal cell cancer: a case-control study. Hormones (Athens) 11(3):308–315

    Google Scholar 

  209. Spyridopoulos TN, Petridou ET, Dessypris N, Terzidis A, Skalkidou A, Deliveliotis C, Chrousos GP (2009) Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens) 8(1):39–46

    Google Scholar 

  210. Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M (2008) Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 38(2):106–111

    PubMed  Google Scholar 

  211. Horiguchi A, Sumitomo M, Asakuma J, Asano T, Zheng R, Nanus DM, Hayakawa M (2006) Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 176(4 Pt 1):1631–1635

    CAS  PubMed  Google Scholar 

  212. Pinthus JH, Kleinmann N, Tisdale B, Chatterjee S, Lu JP, Gillis A, Hamlet T, Singh G, Farrokhyar F, Kapoor A (2008) Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 54(4):866–873

    CAS  PubMed  Google Scholar 

  213. Rasmuson T, Grankvist K, Jacobsen J, Olsson T, Ljungberg B (2004) Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43(8):744–748

    CAS  PubMed  Google Scholar 

  214. Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, Mantzoros CS (2007) Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 120(7):1573–1578

    CAS  PubMed  Google Scholar 

  215. Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K (2009) Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 181(3):1004–1012, discussion 1012

    PubMed  Google Scholar 

  216. Dupont J, Le Roith D (2001) Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol Pathol 54(3):149–154

    CAS  PubMed  PubMed Central  Google Scholar 

  217. Hamelers IH, Steenbergh PH (2003) Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer 10(2):331–345

    CAS  PubMed  Google Scholar 

  218. Poretsky L, Kalin MF (1987) The gonadotropic function of insulin. Endocr Rev 8(2):132–141

    CAS  PubMed  Google Scholar 

  219. Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H, Tourniaire J (1991) Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 40(4–6):841–849

    CAS  PubMed  Google Scholar 

  220. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16(2):143–163

    CAS  PubMed  Google Scholar 

  221. Maor S, Papa MZ, Yarden RI, Friedman E, Lerenthal Y, Lee SW, Mayer D, Werner H (2007) Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1. Horm Metab Res 39(3):179–185

    CAS  PubMed  Google Scholar 

  222. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87–91

    CAS  PubMed  Google Scholar 

  223. Purohit A, Newman SP, Reed MJ (2002) The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 4(2):65–69

    CAS  PubMed  PubMed Central  Google Scholar 

  224. Gonullu G, Ersoy C, Ersoy A, Evrensel T, Basturk B, Kurt E, Oral B, Gokgoz S, Manavoglu O (2005) Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine 31(4):264–269

    CAS  PubMed  Google Scholar 

  225. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9(7):414–417

    CAS  PubMed  Google Scholar 

  226. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290(3):1084–1089

    CAS  PubMed  Google Scholar 

  227. Gaudet MM, Falk RT, Gierach GL, Lacey JV Jr, Graubard BI, Dorgan JF, Brinton LA (2010) Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol 34(5):580–586

    CAS  PubMed  PubMed Central  Google Scholar 

  228. Tworoger SS, Mantzoros C, Hankinson SE (2007) Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity (Silver Spring) 15(9):2217–2224

    CAS  Google Scholar 

  229. Wildman RP, Wang D, Fernandez I, Mancuso P, Santoro N, Scherer PE, Sowers MR (2012) Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) 21:629–636

    Google Scholar 

  230. Szymanska E, Bouwman J, Strassburg K, Vervoort J, Kangas AJ, Soininen P, Ala-Korpela M, Westerhuis J, van Duynhoven JP, Mela DJ, Macdonald IA, Vreeken RJ, Smilde AK, Jacobs DM (2012) Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: towards metabolomics diagnostics. OMICS 16(12):652–667

    CAS  PubMed  Google Scholar 

  231. Wells JC (2012) Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity. Obes Rev 13(Suppl 2):14–29

    PubMed  Google Scholar 

  232. Muller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A (2012) Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 13(Suppl 2):6–13

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EpidStat Institute, 2100 Commonwealth Blvd, Suite 203, Ann Arbor, MI, 48105, USA

    Sarah S. Cohen

  2. Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, 2525 West End Avenue, Suite 600, Nashville, TN, 37203, USA

    Loren Lipworth

Authors
  1. Sarah S. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loren Lipworth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Loren Lipworth .

Editor information

Editors and Affiliations

  1. Department of Community Health Sciences, Boston University, Boston, Massachusetts, USA

    Deborah J. Bowen

  2. Boston University, Boston, Massachusetts, USA

    Gerald V. Denis

  3. Center for Science, Health & Society, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

    Nathan A. Berger

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cohen, S.S., Lipworth, L. (2014). Role of Ethnic Differences in Mediators of Energy Balance. In: Bowen, D., Denis, G., Berger, N. (eds) Impact of Energy Balance on Cancer Disparities. Energy Balance and Cancer, vol 9. Springer, Cham. https://doi.org/10.1007/978-3-319-06103-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06103-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06102-3

  • Online ISBN: 978-3-319-06103-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation